AFA
IDXX icon

Abacus FCF Advisors’s Idexx Laboratories IDXX Stock Holding History

Abacus FCF Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,758
Closed -$1.26M – 94
2019
Q4 		$1.26M Sell
4,758
-108
-2% -$28.5K 0.99% 65
2019
Q3 		$1.32M Buy
4,866
+11
+0.2% +$3.06K 1.09% 33
2019
Q2 		$1.34M Sell
4,855
-1,950
-29% -$480K 1.1% 27
2019
Q1 		$1.52M Buy
6,805
+322
+5% +$66.5K 1.18% 20
2018
Q4 		$1.21M Buy
+6,483
New +$1.33M 1.11% 30
2015
Q1 		– Sell
-22,328
Closed -$1.66M – 115
2014
Q4 		$1.66M Buy
+22,328
New +$1.57M 1.02% 82

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Abacus FCF Advisors's IDXX Position: Q1 2020 in Review

Abacus FCF Advisors sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 4,758 shares — an estimated $1.26M sold.

Abacus FCF Advisors first reported a position in IDXX in Q4 2014 and held it in 6 quarters. The position peaked at $1.66M in Q4 2014. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • Abacus FCF Advisors reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
  • Abacus FCF Advisors sold 4,758 Idexx Laboratories shares in Q1 2020, an estimated $1.26M.
  • Abacus FCF Advisors first reported a position in Idexx Laboratories in Q4 2014 and held it in 6 quarters.
  • Abacus FCF Advisors's Idexx Laboratories position peaked at $1.66M in Q4 2014.
  • 748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Abacus FCF Advisors's 13F filing for Q1 2020, filed 21 Apr 2020.